# TG Therapeutics, Inc. (TGTX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | $123M |
| 2024 | $42M |
| 2023 | $21M |
| 2022 | -$193M |
| 2021 | -$345M |
| 2020 | -$274M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2026-03-31 | $35M |
| 2025-12-31 | $50M |
| 2025-09-30 | $29M |
| 2025-06-30 | $35M |
| 2025-03-31 | $9M |
| 2024-12-31 | $30M |

Source: [CompaniesByCap](https://companiesbycap.com/company/TGTX/operating-income)